SpringWorks Therapeutics’ (SWTX) Buy Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $74.00 price objective on the stock. A number of other brokerages have also recently commented on SWTX. Guggenheim cut their price target on shares of SpringWorks […]
HC Wainwright reissued their buy rating on shares of SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $74.00 price objective on the stock. A number of other brokerages have also recently commented on SWTX. Guggenheim cut their price target on shares of SpringWorks […]
